ProCE Banner Activity

Antibody–Drug Conjugates, Bispecific Antibodies and CAR T-Cell Therapies in Relapsed/Refractory Multiple Myeloma

Slideset

Downloadable slideset from a live webinar covering the latest safety and efficacy data for antibody–drug conjugates, bispecific antibodies, and CAR T-Cell therapies in the management of relapsed/refractory multiple myeloma

Released: July 24, 2024

Expiration: July 23, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Sanofi.

Sanofi